ReviewThe Surgical clinics of North America2009
Sporadic and familial medullary thyroid carcinoma: state of the art.
Review in The Surgical clinics of North America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 75 citations in OpenAlex.
- Mechanistic insights into ferroptosis in thyroid cancer and its therapeutic implications.Apoptosis : an international journal on programmed cell death · 2026Review
- Quantitative Ultrasound Grayscale Analysis and Size of Benign and Malignant Solid Thyroid Nodules.Tomography (Ann Arbor, Mich.) · 2025Article
- Cytology-Radiology Correlation Series: Thyroid cytopathology.Cancer cytopathology · 2025Review
- Continued rise in the incidence of thyroid cancer in Iran: true increase or overdiagnosis?Journal of diabetes and metabolic disorders · 2025Article
- Application and limitations of ultrasound for the early diagnosis of thyroid cancer: a systematic review and meta-analysis.American journal of translational research · 2025Article
- Review
- Two sisters diagnosed with familial paraganglioma syndrome type 1 (FPGL1) and multiple endocrine neoplasia type 2A (MEN2A).World journal of surgical oncology · 2024Article
- Carney Complex and Its Association With Thyroid Cancer, Molecular Pathway, and Treatment.Cureus · 2023Review
- Multikinase Inhibitor Treatment Patterns for Advanced Thyroid Cancer in Japan: An Administrative Claims Database Study.Drugs - real world outcomes · 2023Article
- Preoperative serum calcitonin may improve initial surgery for medullary thyroid cancer in patients with indeterminate cytology.ANZ journal of surgery · 2022Article
- Review
- Review
- Medullary Thyroid Cancer in Patients Older than 45-Epidemiologic Trends and Predictors of Survival.Cancers · 2020Article
- Recurrent spinal metastasis of a sporadic medullary carcinoma of the thyroid after radiation therapy: a case report and review of the literature.Clinical case reports · 2016Article
- Advanced thyroid cancers: new era of treatment.Medical oncology (Northwood, London, England) · 2014Review
- Treating medullary thyroid carcinoma in a tertiary center. Current trends and review of the literature.Hippokratia · 2014Article
- Pheochromocytoma in an 8-year-old patient with multiple endocrine neoplasia type 2A: implications for screening.Journal of surgical oncology · 2013Article
- Familial isolated hyperparathyroidism: role of intra operative parathormone assay.The Indian journal of surgery · 2012Article
- Sporadic medullary thyroid carcinoma with a pedunculated intraluminal internal jugular vein recurrence: A case report and literature review.International journal of surgery case reports · 2012Article
- Thyroid cancer: pathogenesis and targeted therapy.Therapeutic advances in endocrinology and metabolism · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Medullary thyroid cancer (MTC) accounts for 5% to 10% of all thyroid cancers. The high frequency of familial cases mandates screening and genetic testing. The aggressiveness and age of onset of familial MTC differs depending on the specific genetic mutation, and this should determine the timing and extent of surgery. Sporadic MTC can present at any age, and it is usually associated with a palpable mass and the presence of nodal metastases. Surgery is standard treatment for any patient presenting with resectable MTC. Further studies are needed to investigate the role of radiation therapy in the palliation and local control of postresection and advanced-stage MTC. New systemic therapies for metastatic disease are being investigated. Targeted molecular therapies, based on knowledge of the pathways affected by RET mutations, are being tested in multiple clinical trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.